Clinical Trial Update: Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol [Phase 2, Phase 3]

View source ↗

Summary

A multicenter Phase 2/3 pediatric trial protocol for newly diagnosed intermediate/high risk B-cell acute lymphoblastic leukemia is currently recruiting in China…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• B-cell Acute Lymphoblastic Leukemia

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Acute Lymphoblastic Leukemia ALL, Childhood Leukemia, Acute Lymphoblastic | Phase 2, Phase 3 | Status: RECRUITING